Austrian Biotech Database

SHANGHAI, Dec. 4, 2019 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited (Stock code: "Ping An Good Doctor", 1833.HK), one of the world's leading healthcare ecosystem platforms, signed a strategic collaboration agreement today with Merck, a leading science and technology... Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019

Merck and Ping An Good Doctor Form Strategic Collaboration to Advance Intelligent Healthcare in China

SHANGHAI, Dec. 4, 2019 /PRNewswire/ -- Merck, a leading science and technology company, signed a strategic collaboration agreement today with one of the world's leading healthcare ecosystem platforms, Ping An Healthcare and Technology Company Limited (Stock code: "Ping An Good Doctor", 1833.HK).... Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019

Related companies: HOOKIPA Pharma Inc.

Novo Nordisk A/S – Share repurchase programme

By: Nasdaq / GlobenewsWire - 25 Nov 2019

Sanofi: information concerning the total number of voting rights and shares, October 2019

By: Nasdaq / GlobenewsWire - 25 Nov 2019

Novo Nordisk expects to meet its current long-term financial targets and introduces strategic aspirations at the Capital Markets Day 2019

By: Nasdaq / GlobenewsWire - 20 Nov 2019

Related companies: HOOKIPA Pharma Inc.

1 2 3 4 5 6 »

Looking for companies outside of Austria?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

December 2019
- Marseille: BioFIT
- London: Genesis 2019
- London: The Pharma Business Development Course

See Events »

Add an Event »

Latest company news

Sanofi : Positive results presented from pivotal Phase 3 trial of sutimlimab in people with cold agglutinin disease
10 Dec 2019 (GlobenewsWire)

Sanofi and Regeneron announce intent to restructure Antibody collaboration for Kevzara® (sarilumab) and Praluent® (alirocumab)
10 Dec 2019 (GlobenewsWire)

Sanofi CEO unveils new strategy to drive innovation and growth
09 Dec 2019 (GlobenewsWire)

News in the Life Sciences Industry

Sanofi : Positive results presented from pivotal Phase 3 trial of sutimlimab in people with cold agglutinin disease

Sanofi and Regeneron announce intent to restructure Antibody collaboration for Kevzara® (sarilumab) and Praluent® (alirocumab)

Sanofi CEO unveils new strategy to drive innovation and growth

Novo Nordisk A/S – Share repurchase programme

Valneva Appoints Renowned Vaccinologists Stanley Plotkin and Anna Durbin to its Scientific Advisory Board

Sanofi : Sanofi to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 Billion

Valneva to Conduct Investor and Partnering Meetings during the 38th Annual J.P. Morgan Healthcare Conference

Ping An Good Doctor and Merck Form Strategic Collaboration to Advance Intelligent Healthcare in China

Merck and Ping An Good Doctor Form Strategic Collaboration to Advance Intelligent Healthcare in China

Novo Nordisk A/S - Share repurchase programme

Valneva Announces EMA Approval of IXIARO® Shelf Life Extension to 36 Months

HOOKIPA Pharma to Present at Piper Jaffray 31st Annual Healthcare Conference

Novo Nordisk A/S – Share repurchase programme

Sanofi: information concerning the total number of voting rights and shares, October 2019

Novo Nordisk expects to meet its current long-term financial targets and introduces strategic aspirations at the Capital Markets Day 2019

Novo Nordisk A/S – Share repurchase programme

Valneva Reports Excellent Final Phase 1 Results for its Chikungunya Vaccine Candidate, Confirms Plans

Trading in Novo Nordisk shares by board members, executives and associated persons on 14 November 2019

Valneva Announces Appointments of Two Leading Vaccine Experts to its Scientific Advisory Board

HOOKIPA Pharma Reports Third Quarter 2019 Financial Results and Provides a Corporate Update

Looking for companies outside of Austria?

Partners

Upcoming Life Sciences Events

Latest company news